Montis Biosciences
Meise
About Montis Biosciences
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.3M
- Funding stage: Seed
- Last round: Grant (Jun 2021)
- Website: montisbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/montis-biosciences-35826 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.